Cochlear shares drop 41 percent after profit downgrade
Cochlear shares fell 41 percent after the firm cut its profit outlook. Weak demand and Middle East conflict impacts drove the record daily share decline.
Shares of the Australia hearing implant manufacturer COCHLEAR LTD experienced a historic decline on Wednesday, falling nearly 41% after the company significantly lowered its annual earnings forecast. The record daily drop saw the stock close at A$99.58, its lowest level since March 2016, as investors reacted to warnings of weakening demand and geopolitical instability.
The company revised its underlying net profit expectations for fiscal year 2026 to a range of A$290 million to A$330 million. This represents a sharp reduction from the previous guidance of A$435 million to A$460 million and falls well below the Visible Alpha consensus estimate of A$402.5 million. Management attributed the downgrade to a combination of softening trading conditions and uncertainty fueled by conflict in the Middle East, which has begun to impact global supply chains and consumer confidence.
